2024-03-29T08:53:54Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_63978C9C55C1
2024-03-23T02:27:15Z
openaire
documents
urnserval
serval:BIB_63978C9C55C1
Efficacy, tolerability and development of resistance in HIV-positive patients treated with fluconazole for secondary prevention of oropharyngeal candidiasis: a randomized, double-blind, placebo-controlled trial.
10.1093/jac/dkf101
000177357500011
12161404
Pagani
J.L.
author
Chave
J.P.
author
Csajka
C.
author
Glauser
M.P.
author
Bille
J.
author
article
2002-08
The Journal of antimicrobial chemotherapy
0305-7453
0305-7453
journal
50
2
231-240
AIDS-Related Opportunistic Infections/prevention & control
Adult
Candidiasis, Oral/prevention & control
Double-Blind Method
Drug Resistance, Fungal
Fluconazole/adverse effects
Fluconazole/pharmacology
Fluconazole/therapeutic use
HIV Seropositivity/drug therapy
Humans
Male
Patients
Prospective Studies
Secondary Prevention
eng
60_published
true
peer-reviewed
Publication types: Clinical Trial ; Comparative Study ; Journal Article ; Randomized Controlled Trial
Publication Status: ppublish
https://serval.unil.ch/notice/serval:BIB_63978C9C55C1
https://serval.unil.ch/resource/serval:BIB_63978C9C55C1.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_63978C9C55C19
Copying allowed only for non-profit organizations